MedTrace Logo

The Role of Salivary Alpha Amylase in Sepsis

NCT04549740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-05-01

No results posted yet for this study

Summary

Critical illness may be induced by different underlying life-threatening diseases, such as infection, sepsis, trauma, respiratory insufficiency or hypoxia and severe neurological status. The associated endocrine, nervous, metabolic and immunological changes are defined as acute stress syndrome. Salivary alpha-amylase is secreted from the salivary glands mainly in response to beta-adrenergic stimuli. Salivary alpha-amylase (sAA) has gained rapid popularity as a non-invasive marker of sympathetic nervous system (SNS) activity.

Conditions

Interventions

DIAGNOSTIC_TEST

salivary alpha amylase level measurement

Saliva samples will be obtained to estimate salivary alpha amylase

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2024-02-20
Completion
2024-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04549740 on ClinicalTrials.gov